ABSTRACT
Although accumulating evidence indicates that proliferation of pre-existing beta-cells is the major mechanism of the maintenance of postnatal beta-cell mass, new beta-cells can be generated from non-beta-cells under certain conditions in vitro. We have recently shown directly by Cre/loxP-based cell lineage tracing that adult mouse pancreatic acinar cells can be transdifferentiated into insulin-secreting cells in vitro. These newly made cells secrete insulin in response to glucose and other secretagogues, but their secretory capacity is still low compared to that of native beta-cells. To improve the efficiency of generation of insulin-secreting cells from nonbeta cells, it is critical to understand the molecular mechanism of such transdifferentiation. Since pancreatic acinar cells are the most abundant cell type in the pancreas, their utilization as a source of surrogate beta-cells is an intriguing approach to cell replacement therapy for type 1 diabetes. This review focuses on current knowledge of the regeneration of pancreatic beta-cells and transdifferentiation of pancreatic acinar-cells into insulinsecreting cells.
INTRODUCTION
Insulin has been in general use in the treatment of diabetes with absolute insulin deficiency since its discovery.
However, normal pancreatic beta-cells continually adjust insulin secretion in response to varying blood glucose levels, while daily exogenous insulin administration cannot maintain blood glucose levels within the narrow physiological range that protects from development of the various diabetic complications, and more precise administration is impracticable.
Thus, transplantation of insulin-secreting cells generated from stem (or progenitor) cells is a most promising therapeutic approach to treatment of insulin-deficient diabetes (1) (2) (3) . Although it has been reported that embryonic stem (ES) cells can be manipulated to produce insulin (4-7), there are several obstacles to their clinical use. Transplantation of ES cell derivatives into human recipients can result in the formation of ES cell-derived tumors (8) . Ethical problems arise in the acquisition of human ES cells (9) . In addition, it has been suggested that both the production and the release of insulin in such manipulated ES cells may be abnormal (10,11).
On the other hand, recent studies have shown that insulin-secreting cells can be generated in vitro from adult non-beta-cells including mouse and human pancreatic duct cells (12) (13) (14) , rat hepatic oval cells (15) , and mouse bone marrow cells (16) . Pancreatic acinar cells represent the most abundant cell type in the pancreas. In addition, a large number of pancreatic acinar cells can readily be obtained as a byproduct of islet transplantation. Considering that all types of pancreatic cells originate from the same stem cells (17) , the generation of transplantable insulin-secreting beta-cells from pancreatic acinar cells would seem to be feasible. Indeed, we and others have shown that isolated pancreatic acinar cells can convert into insulin-secreting cells under certain conditions (18) (19) (20) . However, full differentiation into beta-cells has not been achieved, and little is known of the signaling pathways involved in the regeneration of pancreatic beta-cells. Thus, clarification of the mechanism of pancreatic beta-cell regeneration should be important for not only deepening our understanding of the physiology of pancreatic islets but also providing a basis for strategy of cell replacement therapy for diabetes mellitus.
DEVELOPMENTAL ASPECTS OF PANCREATIC CELLS

Early development of the pancreas
The pancreas is an organ comprising two distinct populations of cells, exocrine cells producing and secreting digestive enzymes through the duct system into the gut and endocrine cells producing and secreting hormones into the bloodstream. Although each of the differentiated pancreatic cell types possesses a different function, all pancreatic cells are differentiated from common progenitor cells in primitive gut. In mouse, formation of the pancreas becomes evident at embryonic day 8.5-9.0 immediately after closure of the anterior endoderm (21) . The pancreas derives from two distinct buds on the foregut. One anlage arises dorsally in the duodenal part on the foregut and the other is formed ventral to the hepatic endoderm, which then fuse to form the pancreas. However, little is known of the molecular mechanisms of early specification of the gut tube in the formation of the pancreatic buds, although inductive signals from adjacent germ layers are thought to be involved (17, 22) . It has been suggested that signals from the notochord and endothelium specify the location of the pancreatic epithelium, while those from mesenchyme regulate the size of the pancreas (21).
Cell signals involved in pancreas development
Notch signaling has been thought to play a critical role in cell type specification of the pancreas (23, 24) . The Notch pathway acts on binary cell fate by lateral inhibition, which is required in the developing pancreas to maintain the progenitor cell population (25). The Notch receptor is a single transmembrane protein composed of extracellular, transmembrane, and intracellular domains. Notch ligand Delta/Serrate/Lag2 (DSL) family proteins on neighboring cells activate the Notch pathway, leading to proteolysis that releases the Notch intracellular domain (NICD) and results in the expression of Hairy and Enhancer-of-split protein 1 (Hes1), a downstream molecule in the Notch signaling pathway (23) .
Suppression of Notch signaling depletes the progenitor pool by precocious differentiation and upregulation of neurogenin 3 (Ngn3) (26, 27) . Conversely, activation of Notch signaling prevents endocrine differentiation (24, 28) . Thus, the Notch signaling pathway is involved in the regulation of cell differentiation and proliferation in developing pancreas.
Interaction between epithelial and mesenchymal cells also participates in pancreas development. For example, fibroblast growth factor 10 (FGF10) released from mesenchyme plays an important role in the maintenance Pdx1-positive epithelial progenitors in the pancreas (29) . While lack of FGF10 expression results in severe growth retardation of the pancreas (29) , ectopic expression of FGF10 by pancreas-duodenum homeobox 1 (Pdx1) promoter causes abrogation of pancreatic cell differentiation and sustained proliferation of pancreatic progenitor cells (30, 31) . Furthermore, interplay between FGF10 and Notch signaling has been reported (32, 33) . Epidermal growth factor (EGF) signaling also may be involved in pancreas development. EGF receptor family members (ErbBs) are known to be expressed in developing pancreas (33) , and mutation in the ErbB3 receptor impairs the development of pancreas (34) . EGF also was shown to promote proliferation of mesenchyme-depleted rat pancreatic epithelium in vitro (35) .
Moreover, transforming growth factor (TGF)-beta signaling is important for growth and differentiation of pancreatic cells. The TGF-beta superfamily consists of TGF-beta, bone morphogenetic proteins (BMPs), and activins, which bind to two types of serine/threonine kinase receptors. A dominant-negative form of the type II receptor of TGF-beta increases proliferation and impairs differentiation of exocrine pancreas (46) .
In addition, hyperplasia of pancreatic islets has been reported in transgenic mice expressing a dominant-negative activin receptor (37) . Furthermore, expression of BMPs is detected in developing pancreas (38) (39) (40) , suggesting their roles in pancreas development.
Transcription factors in developing pancreas
Pancreatic progenitors within the foregut epithelium can be discerned by the expression of Pdx1, which appears at e8.5 in the foregut endoderm and is expressed throughout the pancreatic epithelium at e9.5 (41) . Pdx1 expression is lost in mature acinar and ductal cells in adult pancreas, but is maintained in differentiated pancreatic beta-cells.
In Pdx1-deficient mice, both pancreatic buds form initially, but are arrested at a very early stage of development, resulting in agenesis of the pancreas (42) . Thus, Pdx1 is essential for the growth of pancreatic buds and is considered to be the master regulator of pancreas development. Pancreas transcription factor 1a (Ptf1a) is also expressed throughout the developing pancreas beginning at e9.5 (43) , and has been shown to be required for the growth of pancreatic buds (44) . Ptf1a is maintained in differentiated pancreatic acinar cells, while it is down-regulated in endocrine and duct cells. In addition, forkhead box a2 (Foxa2) is known to activate Pdx1 expression (45). Moreover, the basic-helix-loop-helix (bHLH) transcription factor Ngn3, a downstream target of hepatocyte nuclear factor 6 (HNF6), is expressed in pancreatic endocrine progenitor cells, and has been shown to be required for endocrine differentiation. Ngn3-deficient mice lack endocrine cells completely (46) . A lineage tracing study by Gu et al. has shown that Ngn3-expressing cells give rise to all four endocrine cell types (47) . Ngn3 induces the expression of neurogenic differentiation 1 (NeuroD1) and paired box gene 4 (Pax4), both of which are essential for beta-cell function. However, the expression of Ngn3 itself is lost in differentiated endocrine cells. NeuroD1 induces the expression of genes characteristic of pancreatic beta-cells, including insulin and the molecules required for regulated excytosis (48) . Collombat et al. reported that Aristaless-related homeobox (Arx) plays an important role in the specification of alpha-versus betacells in a complementary fashion to Pax4 (49).
MAINTENANCE OF ADULT PANCREATIC BETA-CELLS
Neogenesis and regeneration in the pancreas
In general, adult tissues and organs are thought to be maintained by the stem cell system, in which stem cells having the potential to self-renew give rise to progenitor cells, which then proliferate and differentiate into the several types of functionally differentiated cells ( Figure 1 ). The primary role of adult (tissue-specific) stem cells is to maintain and repair the tissue in which they reside. The best-known example of the stem cell system is the generation of blood cells. Hematopoietic stem cells (HSCs) reside in bone marrow in adult and have multipotency to differentiate into all types of mature blood cells (50, 51) . HSCs also have the potential to self-renew, although whether or not asymmetric cell division, in which of one daughter cell that remains a stem cell and one daughter cell that differentiates is generated, occurs during self-renewal is not known (50, 51) . HSCs give rise to committed precursor cells such as proerythroblasts, myeloblasts, lymphoblasts, monoblasts, and megakaryoblasts, which differentiate into mature blood cells (50, 51) . A similar stem cell system is found in small intestine, which undergoes constant renewal and differentiation from stem cells throughout the lifetime (52) . In contrast to blood cells and intestinal epithelial cells that are required to renew everyday, cells in the pancreas seem to be static. However, in certain situations including pathological conditions and experimental models, remodeling of the pancreas occurs. In transgenic mice expressing interferon (IFN)-gamma specifically in pancreatic beta-cells, a dramatic proliferation of pancreatic ductal cells and the appearance of primitive endocrine cells and their subsequent differentiation into endocrine cells has been reported (53) . During regeneration, transitional intermediate cells expressing both carbonic anhydrase II and amylase (54) , and bearing both endocrine and exocrine granules (55) appear. The authors speculate from these findings that pancreatic duct cells represent facultative progenitors in adult pancreas. However, their results also suggest that pancreatic acinar cells give rise to intermediate cells, which have characteristics of pancreatic duct cells, and then differentiate into endocrine cells. It has been reported that overexpression of TGF-alpha induces expansion of Pdx-1-expressing ductal epithelium in the pancreas, and that focal areas of islet neogenesis are observed (56) . Since pancreatic acinar cells isolated from TGF-alpha transgenic mice convert into ductal cells (57, 58) , the expanded pancreatic ductal cells expressing Pdx1 in these mice may well be derived from pancreatic acinar cells.
In addition to these genetically engineered mice, some pancreatic injury models have been shown to exhibit pancreas regeneration. After ligation of the pancreatic duct in rats, replacement of exocrine acini by duct-like structures is observed (59) . This acinoductal metaplasia has been thought to be at least in part due to transdifferentiation of amylase-positive pancreatic acinar cells into amylase-negative and cytokeratin-positive ductlike cells (60) . By treating the rats with dexamethason to inhibit loss of amylase expression, transitional cells coexpressing amylase and cytokeratin 20 (CK20) were detected (60) , supporting the notion of acinar-to-ductal transdifferentiation. Moreover, insulin-positive cells that also express amylase were found, indicating acinar-toendocrine transdifferentiation.
The beta-cell toxin streptozotocin (STZ) is known to cause rapid and massive beta-cell death. In some studies, it has been found that insulin-positive cells reappear after the loss of pancreatic beta-cells by STZ treatment (61, 62) . During regeneration, somatostatin/Pdx1-double positive cells, which subsequently differentiate into somatostatin/insulin/Pdx1-positive cells, are found in pancreatic islets. Exogenous administration of insulin enhances this beta-cell differentiation and maturation. These findings suggest that adult pancreatic islets contain a progenitor cell population that can be differentiated into insulin-positive beta-cells following islet injury. Thus, although the adult stem cells responsible for the maintenace of the pancreas have not yet been identified, these results sugget the existence of cells with stem cell-like capacity in adult pancreas. The potential candidates include pancreatic islets (62) (63) (64) , duct cells (65) , and acinar cells (18) (19) (20) .
It is noteworthy that all of these models of regeneration involve injury of the pancreas. Thus, while the signals inducing or initiating beta-cell regeneration remain largely unknown, growth factors and inflammatory cytokines are implicated in the process. It has been reported that the Notch pathway is involved in pancreatic acinar-to-ductal transdifferentiation in TGF-alpha transgenic mice (57) . When gamma-secretase inhibitor, which prevents cleavage of Notch receptors, was applied to isolated pancreatic acinar cells from TGF-alpha transgenic mice, induction of Hes1 expression was eliminated and formation of duct-like structures was reduced. The EGF receptor kinase inhibitor AG1478 completely abolished induction of acinar-to-ductal transdifferentiation by TGFalpha, but had no effect on transdifferentiation by the activated intercellular domain of Notch1. Thus, activation of the Notch pathway is a downstream mediator of EGF receptor signaling in pancreatic acinar-to-ductal transdifferentiation (57).
Pancreatic tissue-specific stem/progenitor cells
Many investigators have attempted to identify stem/progenitor cells in adult pancreas. Zulewski et al. showed that cells expressing the neural stem cell marker nestin occur in human and rat pancreatic islets, and that these cells can be isolated and cultured for a long time (63) . It has been shown that cultured nestin-positive cells can be differentiated into insulin-producing cells (63, 64) , and that such cells from human fetal pancreas when transplanted can be expanded and differentiated into islet-like cell clusters, which can reverse hyperglycemia in diabetic mice (66) . Clonal identification of multipotent precursors from adult mouse pancreas has recently been reported (67) . These candidate progenitor cells proliferate in the serumfree conditions used for neural stem cell (NSC) culture, and form spherical cell clusters like NSCs by floating culture. The spheroids containing progenitor cells can be derived from both pancreatic islets and duct cell populations. Although the cells were generated from both nestinpositive and nestin-negative fractions, they all expressed nestin during the expansion period. Interestingly, the cells in the spherical clusters show characteristics of both pancreatic and neural precursors. Moreover, the potential progenitors give rise to multiple types of neural cells including neurons and glial cells, and also differentiate into insulin-producing (beta) cells, glucagon-producing (alpha) cells, and somatostatin-producing (delta) cells. The insulin-producing cells derived from these progenitors are glucose-competent in terms of Ca 2+ responsiveness and insulin secretion. The pancreatic islet-like cells are generated from the spheroids by culture onto Matrigel matrix-coated plates without the addition of mitogens. However, since the Matrigel basement membrane contains various growth factors, the signals responsible for islet cell generation could not be identified. Suzuki et al. also reported isolation of pancreatic progenitor cells from adult mouse by using fluorescence-activated cell sorting (FACS) (68) . The isolated cells express cMet, the receptors for hepatocyte growth factor (HGF), but do not express hematopoietic and vascular endothelial antigens such as CD45, TER119, c-Kit, and Flk-1. Thus, HGF/c-Met signaling may play an important role in the maintenance of these progenitor-like cells. The cells formed clonal colonies in vitro and differentiated into multiple pancreatic lineages from single cells. As glucagon-like peptide-1 (GLP-1) was used in that study, GLP-1-mediated cAMP signaling may well participate in the differentiation of the candidate progenitor cells into mature pancreatic cells.
Expansion of pre-existing beta-cells
It is known that pancreatic beta-cell mass expands through adulthood (70) (71) (72) (73) . Although histological analysis has demonstrated that neogenesis or regeneration of pancreatic beta-cells occurs in certain conditions, the cellular origin of the new beta-cells has not been demonstrated. Recent studies using genetic cell lineage tracing or other sophisticated methods suggest that adult pancreatic beta-cells are not derived from non-beta-cells (74) (75) (76) . By using genetic cell lineage tracing, Dor et al. demonstrated that adult pancreatic beta-cells in mice are maintained predominantly by self-replication of preexisting beta-cells (74) . They labeled pancreatic beta-cells selectively with human alkaline phosphatase by Cre-loxPbased conditional recombination in adult pancreas and chased the fate of pre-existing beta-cells. In this system, when new beta-cells in adult pancreas are generated from non-beta-cells such as stem/progenitor cells, the frequency of the labeled beta-cells should decrease after a chase period. The results indicated that the labeling frequency of the beta-cells remained unchanged, indicating that new beta-cells were generated primarily from pre-existing betacells. They conclude that terminally differentiated betacells retain proliferative capacity and cast doubt on a significant role for adult stem cells in beta-cell replenishment (74). Georgia and Bhushan reported that during neonatal development, cyclin D2 expression in the endocrine pancreas coincided with the replication of endocrine cells and a massive increase in islet mass (75) . Cyclin D2 is not required for exocrine and ductal cell proliferation but is required for replication of endocrine cells. In cyclin D2
-/-mice, pancreatic islets are much smaller and beta-cell mass is reduced to 25% in comparison with wild type mice. Thus, cyclin D2 plays a key role in beta-cell replication, which may be the primary mechanism for maintaining postnatal beta-cell mass (75) . Furthermore, Teta et al. showed by using a DNA analog-based lineagetracing technique that unlike gastrointestinal and skin epithelia, specialized progenitors do not contribute to adult beta-cell mass, not even during acute beta-cell regeneration (76) . Instead, adult beta-cells exhibit equal proliferation potential, and expand from within a vast and uniform pool of mature beta-cells (77) . Thus, it is likely that pancreatic beta-cell mass is maintained primarily by self-replication of pre-existing beta-cells in adult mice, although the existence of pancreatic tissue-specific stem/progenitor cells cannot be excluded.
TRANSDIFFERENTIATION IN THE PANCREAS
Plasticity of pancreatic cells
Although it has been thought that terminally differentiated cells do not change their phenotype, accumulating evidence suggests that phenotypic plasticity is retained in differentiated cells. Transdifferentiation, the conversion of one already differentiated cell type to another, is a paradigm of phenotypic plasticity in adult cells. In general, such phenotypic change occurs in tissues with chronic damage and in tissue regeneration (78) . The pancreas is an organ in which metaplasia, a pathological state involving transdifferentiation (79, 80) , frequently occurs. For example, hepatocyte-like cells appear in human pancreatic cancer in some cases (81) , and experimental conditions such as copper depletion can lead to the development of pancreatic hepatocytes in rodents (82, 83) . Moreover, metaplastic hepatocytes in ciprofibratetreated rat pancreas have been shown to originate from pancreatic exocrine acinar cells (84) . Pancreatic acinar cells also can convert into ductal cells, and direct evidence for acinar-to-ductal transdifferentiation has been provided both in vitro (20, 58) and in vivo (85,86). In addition, transdifferentiation of insulin-secreting cells from pancreatic exocrine cells has been demonstrated in vitro (19, 20) , and cell lineage tracing has revealed the origin of the newly made insulin-secreting cells to be pancreatic acinar cells (20, 87) .
The signaling mechanisms of transdifferentiation of pancreatic acinar cells are not fully understood. Although, EGF, Notch, and/or leukemia inhibitory factor (LIF)/ (signal transducer and activator of transcription (STAT) signals are thought to be involved in the process (19, 20, 57, 58) , their precise roles are not known. In addition, putative progenitor cell markers such as nestin (58) and protein gene product 9.5 (PGP9.5) (20,88) have been detected in transdifferentiating pancreatic acinar cells, suggesting that dedifferentiated intermediate cells were generated in the course of the transdifferentiation, as seen in lens or tail regeneration in amphibia (89, 90) . However, such dedifferentiated states are transient, and the intermediate cells have not been characterized. Thus, the details of the process of transdifferentiation of pancreatic cells are largely unknown at present.
Beta-cell transdifferentiation
Differentiated pancreatic beta-cells were thought to be static, but several studies have suggested that betacells transdifferentiate into exocrine and duct-like cells in vitro (91, 92) . Yuan et al. reported that cultivation of purified human islets in collagen gel matrix resulted in transformation of islet cells into duct-like structures without insulin expression (91) . In a study by Scmied et al., when purified human pancreatic islets were cultured, endocrine cells gradually transdifferentiated into ductal, acinar, and intermediary cells. After a long period of culture (> 60 days), the endocrine-derived cells were converted into undifferentiated cells expressing neuronspecific enolase, chromogranin A, laminin, vimentin, CK7 and CK19, alpha-1-antitrypsin, TGF-alpha, and EGF receptor (92) . Thus, human islet cells possess plasticity to change their differentiated phenotype in vitro. However, a recent study using genetic cell lineage tracing has found that pre-existing pancreatic beta-cells do not contribute to regeneration or metaplasia in pancreatitis in vivo (93).
Acinar cell transdifferentiation
There are many reports regarding phenotypic plasticity of pancreatic acinar cells. As described above, studies of IFN-gamma transgenic mice (53, 54) , TGF-alpha transgenic mice (56) (57) (58) , and duct ligation models (59) suggest that pancreatic exocrine acinar cells transdifferentiate into ductal and endocrine cells after inflammation. Transdifferentiation of pancreatic acinar cells into ductal cells (58) and insulin-secreting cells (20) has been demonstrated in vitro under certain conditions without gene transfer. In addition, a rat pancreatic tumorderived cell line AR42J, which has features of pancreatic acinar cells, has been shown to differentiate into insulinsecreting cells in the presence of betacellulin and activin A (94) .
In contrast, recent studies have failed to detect transdifferentiation of pancreatic acinar cells either in normal or pathological conditions in vivo (93, 95 (95) . However, these studies do not exclude the possibility of in vitro or ex vivo transdifferentiation of pancreatic acinar cells into pancreatic beta-cells or ductal cells. It should be noted that direct evidence in vivo has been provided for acinar-to-ductal transdifferentiation in transgenic mice persistently expressing Pdx1 in pancreatic acinar cells (85) and mice with cerulein-induced pancreatitis (86) , demonstrating the plasticity of pancreatic acinar cells in their differentiation capacity. Clarification of the mechanism of transdifferentiation is required to explain these discrepancies.
PANCREATIC ACINAR-TO-ENDOCRINE TRANSDIFFERENTIATION
Generation of insulin-secreting cells from pancreatic acinar cells
In vitro generation of insulin-secreting cells (beta-cells) from pancreatic acinar cells has been reported by several groups (18) (19) (20) . Since a large number of pancreatic exocrine cells can be obtained as a byproduct of islet transplantation, the exocrine pancreas is an intriguing source for the generation of transplantable surrogate betacells. Song et al. found that adult rat pancreatic acinar cells transdifferentiated into insulin-expressing cells in vitro (18) . They isolated pancreatic acinar cells from adult rats and cultured the cells in suspension without adding any growth factor and cytokines. Most of the acinar-derived cells lost amylase expression and acquired a ductal (19) . However, neither direct evidence of the origin of these cells nor their precise insulin secretory properties was shown in these studies.
We have established a method for the generation of insulin-secreting cells from pancreatic acinar cells in mice (20) . The pancreatic exocrine cell-enriched fraction was prepared by Ficoll density gradient centrifugation. By this method, pancreatic exocrine cells are recovered as a pellet, and are then stained with dithizone, a zinc-chelating agent, to remove contaminated pre-existing pancreatic betacells. The resulting fraction contains >90% of amylasepositive cells, approximately 5% of cytokeratin-positive cells, and less than 0.01% of insulin-positive cells. The exocrine cell-enriched fractions were then cultured in RPMI-1640 medium supplemented with 0.5% fetal calf serum (FCS) and 20 ng/ml of EGF.
Under these conditions, the cells readily formed aggregates and became smooth spheroids within a few days. When sticky cell culture dishes were used, the cells began to adhere, and formed small monolayer colonies. We found that a subset of the cells in these colonies expressed insulin. Most insulin-positive cells were detected at the peripheral of small colonies.
However, insulin secretion was undetectable under these conditions. When the isolated pancreatic exocrine cells were cultured in suspension using dishes treated with 2-methacryloyloxyethyl phosphorylcholine (MPC), which interferes with cell attachment, insulin production was increased compared to that in monolayer culture. Pancreatic exocrine-derived spheroids could be maintained throughout the culture (Figure 2 ). The frequency of insulin-positive cells was increased to ~5% of total cells on day 4. The insulin-positive cells also expressed C-peptide (Figure 3a) , indicating de novo biosynthesis of insulin in these cells. To determine the cell type that differentiates into insulin-producing cells in exocrine pancreas, we first evaluated the expression of pancreatic cell markers during culture. Both amylase and elastase, which are acinar cell-specific enzymes, were strongly detected before culture (day 0) at both mRNA (RT-PCR) and protein (immunoblotting) levels. However, their expressions were drastically decreased during culture, becoming barely detectable on day 4 and after. In contrast, the ductal marker CK19 was increased. Immunocytochemistry showed that both amylase-and elastase-positive cells comprised more than 90% of total cells in the initial preparation (day 0), but less than 5% 4 days after culture. While CK-positive cells were rare at day 0, CK-positive ductal structures were found frequently at day 4 and day 6. Although insulin-positive cells were generally negative for amylase, a few cells clearly expressed both insulin and amylase. Amylase/CK double-positive cells also were detected.
Similar results were obtained for elastase. Insulin/CK double-positive cells were rarely found, and such cells were not located in well-organized ductal structures (Figure 3b) . These results suggest that the insulin-producing cells in the culture are derived from amylase/elastaseexpressing mature pancreatic acinar cells.
To confirm that the newly-made insulinproducing cells were derived from pancreatic acinar cells, we utilized the method of cell lineage tracing. In this method, ROSA26-loxP-stop-loxP-ECFP reporter mouse (R26R-ECFP) expressing enhanced cyan fluorescent protein (ECFP) that can be activated through the action of Cre recombinase (96) and adenoviruses in which either amylase-2 (Ad-pAmy-Cre) or elastase-1 (AdpEla-Cre) promoter drives the expression of Cre recombinase are used (Figure 4a ). Pancreatic exocrine cells from R26R-ECFP mice were infected with these adenoviruses to label pancreatic acinar cells, and cultured as described.
After the culture, ECFPexpressing insulin-positive cells were frequently found, demonstrating that the insulin-positive cells originate from amylase-expressing pancreatic acinar cells (Figure 4b) (20) . The most important function of pancreatic betacells is glucose-induced insulin secretion, in which several key molecules are known to be involved (97) . Glucose transporters, glucokinase, ATP-sensitive K + (K ATP ) channels, voltage-dependent Ca 2+ channels, molecules associated with the exocytotic machinery (SNAREs), and prohormone convertases (PC1/3 and PC2) are required for proper glucose-induced insulin secretion. The expressions of all of these molecules were induced or up-regulated in pancreatic acinar cells after the culture. The expression profiles of the exocrine pancreas-derived insulin-producing cells became similar to those of the pancreatic islets. In addition, formation of insulin-containing granules was confirmed by immunoelectron microscopy, indicating that these cells can secrete insulin in a regulated manner. Indeed, a high concentration of KCl stimulated insulin secretion from the cells, indicating the occurrence of Ca 2+ -triggered exocytosis in pancreatic acinar-derived cells. Insulin secretion also was increased by glibenclamide, a sulfonylurea widely used in treatment of diabetes, indicating that functional K ATP channels are expressed. Importantly, glucose stimulated insulin secretion from exocrine pancreas-derived cells in a concentrationdependent manner, demonstrating that the cells are glucose responsive. In addition, GLP-1 (7-36 amide), an incretin, potentiated insulin secretion in the presence of relatively high concentrations of glucose, indicating that the cAMPmediated potentiation system also is present in the cells ( Figure 5 ). These results show that pancreatic acinarderived cells have qualitatively similar insulin secretory properties to those of native pancreatic beta-cells. However, insulin content in these pancreatic acinar-derived 
Dedifferentiation during the course of transdifferentiation
During development of the pancreas, several transcription factors are known to play critical roles in betacell differentiation (20) . Pdx1, a transcription factor seen early in the developing pancreas and restricted to beta-cells in adults, was induced in pancreatic acinar-derived cells by the culture at both mRNA and protein levels. Other transcription factors characteristic of endocrine pancreas (NeuroD1, Isl1, Pax6, Nkx2.2, Nkx6.1, Hlxb9, HNF1α, and Foxa1) also were induced. Foxa2 is expressed in early endoderm (98) and all pancreatic cell types including endocrine and exocrine cells in adult (99) . Although we could not detect Foxa2 expression in isolated acinar cells, probably due to the low expression level, Foxa2 was induced at both mRNA and protein levels after the culture. HNF6, which is required for the expression of Foxa2 (100), Insulin secretion was stimulated by 30 mM KCl, 0.1 µM glibenclamide (Glib), 0.1 mM carbachol (CCh), or increased concentrations of glucose (G3; 3 mM, G10; 10 mM, G20; 20 mM) for 60 min. Potentiation by GLP-1 (7-36 amide) (100 nM) is also shown. Data are means ± S.E. of three to seven independent experiments. Reprinted with permission from Ref. 20 with modification.. also was induced. Ptf1a expression was increased by the culture. Although Ptf1a was thought to be an exocrine specific transcription factor (43), a recent study has shown that this factor also is expressed in the pancreatic bud and is required for differentiation into all three cell types (endocrine, exocrine, and duct) of the pancreas (44) . These results suggest that pancreatic acinar cells dedifferentiate into cells having the properties of immature pancreatic cells. Induction of PGP9.5, a potential marker of endocrine progenitors (101) , supports this notion. Thus, it is likely that isolated pancreatic acinar cells first dedifferentiate into cells with properties of undifferentiated pancreatic cells, and then redifferentiate into insulin-secreting cells under these conditions (Figure 6 ).
Signaling mechanisms
We found that enzymatic dissociation of the pancreas leads to activation of the EGF receptor and its downstream signaling. The EGF receptor was not activated before dissociation but was activated (tyrosine phosphrylated) by enzymatic dissociation (Figure 7 and b). When an inhibitor of EGF receptor kinase (AG1478) was applied, transdifferentiation of isolated pancreatic acinar cells into insulin-secreting cells was inhibited (Figure 7c ) (20) , demonstrating that activation of the EGF receptor is essential for the transdifferentiation. In embryonic pancreas, EGF increases the number of undifferentiated endocrine precursor cells, and, upon removal of EGF, a large number of beta-cells are differentiated (35) , suggesting that EGF may be important for the proliferation of endocrine precursors and/or endow the cells with commitment to endocrine lineage. In addition, in TGF-alpha transgenic mice, ductal hyperplasia and pronounced interstitial fibrosis occur in exocrine pancreas (102) . In these mice, numerous duct cells of the pancreas have both zymogen and mucin granules (102) . Islet neogenesis from the metaplastic duct is observed in the pancreas of these transgenic mice (53) . TGF-alpha is a member of the EGF family acting via the EGF receptor. Thus, EGF signaling is also involved in acinar-to-ductal transdifferentiation and islet neogenesis in adult pancreas. In addition, we have found that activation of the PI3-kinase/Akt pathway is essential for in vitro transdifferentiation of pancreatic acinar cells into insulin-secreting cells (KM and SS, unpublished observation) (Figure 6 ).
PERSPECTIVE
Generation of pancreatic insulin-secreting cells from non-beta-cells in vitro represents a potentially useful approach to cell replacement therapy for type 1 diabetes. Accumulating evidence shows that insulin-secreting cells can be generated from pancreatic acinar cells by transdifferentiation in vitro under certain culture conditions. However, such newly made cells are not fully differentiated beta-cells, as assessed by both insulin secretory properties and gene expression profile, compared with native pancreatic beta-cells. Native pancreatic betacells are highly differentiated cells equipped with a well- regulated secretory apparatus of insulin secretion that controls blood glucose levels within a narrow physiological range. Considering that the native pancreatic beta-cells form the three-dimensional structure (islet) with other types of endocrine cells, intercellular communication might be an important factor for full differentiation into mature betacells from non-beta-cells. In addition, cell-to-extracellular matrix contact could also be implicated in the establishment of cell functions. Therefore, molecules associated with cell-to-cell and cell-to-matrix interactions may have roles in the transdifferentiation. In any case, we need to pay more attention to the morphological aspect of newly-made insulin-secreting cells for the use of cell transplantation. Clarification of the molecular mechanisms of such transdifferentiation as well as the acquisition of insulin secretory function in the process may provide a basis for cell replacement therapy in type 1 diabetes.
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